Literature DB >> 1032669

Mechanistic studies on transcorneal permeation of pilocarpine.

J W Sieg, J R Robinson.   

Abstract

The mechanism of corneal pilocarpine penetration was studied in the albino rabbit using radiochemical techniques. The apparent rate and extent of pilocarpine accumulation in the aqueous humor and the various cell layers of the cornea were determined for both intact and abraded eyes. For the first time, drug levels were monitored in the epithelium and stroma-endothelium of the intact cornea using a tissue-scraping technique. In addition, a new postinstillation rinsing method was devised to evaluate the rate of corneal uptake. The results demonstrate a dual role for the corneal epithelium, both as a barrier to drug penetration and as a reservoir for drug in the intact cornea. The transcorneal pilocarpine flux is slower than the data appear to indicate, and previous overestimates of the apparent absorption rate constant are due to parallel elimination processes occurring at the absorption site. Pharmacokinetic parameters were determined for each tissue to generate an overall mechanism for corneal permeation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1032669     DOI: 10.1002/jps.2600651230

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  22 in total

1.  General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.

Authors:  Feng Deng; Veli-Pekka Ranta; Heidi Kidron; Arto Urtti
Journal:  Pharm Res       Date:  2016-07-18       Impact factor: 4.200

2.  Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension.

Authors:  Maxime Le Merdy; Jianghong Fan; Michael B Bolger; Viera Lukacova; Jessica Spires; Eleftheria Tsakalozou; Vikram Patel; Lin Xu; Sharron Stewart; Ashok Chockalingam; Suresh Narayanasamy; Rodney Rouse; Murali Matta; Andrew Babiskin; Darby Kozak; Stephanie Choi; Lei Zhang; Robert Lionberger; Liang Zhao
Journal:  AAPS J       Date:  2019-05-20       Impact factor: 4.009

Review 3.  Treatment of ocular infections with topical antibacterials.

Authors:  J P Leeming
Journal:  Clin Pharmacokinet       Date:  1999-11       Impact factor: 6.447

4.  Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results.

Authors:  Nozomi Kinoshita; Yasuhiro Konno; Naoki Hamada; Yoshinobu Kanda; Machiko Shimmura-Tomita; Akihiro Kakehashi
Journal:  Jpn J Ophthalmol       Date:  2018-07-04       Impact factor: 2.447

5.  Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.

Authors:  Pravin Kondiba Pawar; Dipak K Majumdar
Journal:  AAPS PharmSciTech       Date:  2006-02-10       Impact factor: 3.246

6.  Gene expression analysis in SV-40 immortalized human corneal epithelial cells cultured with an air-liquid interface.

Authors:  Dario Greco; Kati-Sisko Vellonen; Helen C Turner; Marika Häkli; Timo Tervo; Petri Auvinen; J Mario Wolosin; Arto Urtti
Journal:  Mol Vis       Date:  2010-10-15       Impact factor: 2.367

7.  Ocular pharmacokinetic modeling using corneal absorption and desorption rates from in vitro permeation experiments with cultured corneal epithelial cells.

Authors:  Veli-Pekka Ranta; Mirka Laavola; Elisa Toropainen; Kati-Sisko Vellonen; Anu Talvitie; Arto Urtti
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

8.  Desensitization of the isolated bovine iris sphincter muscles by pilocarpine.

Authors:  R Suzuki; H Yoshino; S Kobayashi
Journal:  Doc Ophthalmol       Date:  1988-05       Impact factor: 2.379

9.  Prolonged pulse-entry of pilocarpine with a soluble drug insert.

Authors:  L Salminen; A Urtti; H Kujari; M Juslin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

10.  Physiologically Based Pharmacokinetic Model to Support Ophthalmic Suspension Product Development.

Authors:  Maxime Le Merdy; Ming-Liang Tan; Andrew Babiskin; Liang Zhao
Journal:  AAPS J       Date:  2020-01-06       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.